SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is seeing intense volatility as traders debate its valuation and near-term prospects, especially given the CEO's past stock sales. Community chatter revolves around whether the stock is overextended, with bears anticipating a significant pullback and bulls defending its long-term potential in the quantum computing sector. Discussions also include potential impacts from upcoming earnings and options expirations.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the community debates recent price action and potential market direction, with discussions ranging from bullish predictions to bearish concerns about a possible cycle top. Community members are actively discussing potential manipulation, the influence of external factors like Trump's policies, and comparing Bitcoin's performance against traditional assets like gold. The conversation also includes speculation about institutional accumulation and the impact of potential regulatory changes on the crypto market.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

PRAX is trending as traders weigh recent price action against news of new price targets and a potential offering. The community is actively discussing entry and exit points, with some eyeing shorting opportunities while others remain bullish. Discussions also revolve around the company's trial results and future potential.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending as investors discuss the company's long-term financial targets, specifically its goal of $60B+ in revenue by FY2030, and its expanded AI ecosystem with Google. The community is weighing the potential of new AI integrations like Agentforce 360 and Gemini, and debating if Salesforce is positioned to capture a larger share of the enterprise AI market. Some analysts are reiterating strong buy ratings, citing an attractive valuation relative to free cash flow despite concerns over growth.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as gold prices surge to record highs, fueled by safe-haven demand amid economic uncertainty and renewed trade tensions. The community is discussing the potential for further gains, the possibility of a pullback, and whether gold is becoming overbought. Some investors are rotating into gold as a hedge against a weakening dollar and potential market instability.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is experiencing significant volatility, driven by concerns around potential impacts from trade tensions and broader market pressures affecting the drone sector. Community discussions revolve around identifying a price floor and debating whether the current downturn presents a buying opportunity or signals deeper issues. Despite the drop, some investors remain confident in the company's long-term prospects, particularly its positioning in the defense and security sectors.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as investors discuss its potential driven by possible government contracts and tech partnerships, with some believing short covering is contributing to the upward momentum. Community members are actively debating the company's valuation and future prospects within the quantum computing sector, with discussions around potential dilution and management strategies. Despite concerns, bullish sentiment persists, fueled by Roth Capital's raised price target and D-Wave's claimed quantum supremacy.

Above Food Ingredients, Inc. engages in operating its subsidiaries, Bite Acquisition Corp. (Bite) and Above Food Corp. (Above Food). The Bite is a blank check company that affects a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Above Food is an ingredient company that provides food products and brands. The company was founded by Lionel Kambeitz on April 18, 2023 and is headquartered in Regina, Canada.

Above Food Ingredients Inc.

ABVE is trending as the stock price experiences volatility, leading to active discussions around short squeezes and potential news catalysts. Community members are debating potential price targets and the impact of options listing, while also highlighting the company's connection to tokenization and gold-backed assets. Some traders express frustration with price manipulation and delayed filings, while others remain confident in the long-term potential.

Earlyworks Co., Ltd. engages in providing blockchain-based technology solutions. It operates its proprietary private blockchain technology, Grid Ledger System (GLS), a hybrid blockchain that combines the technical advantages of blockchain technology and database technology, to leverage blockchain technology in various applications in a range of industries. It offers software and system development services and consulting and solution services. The company was founded by Satoshi Kobayashi and Hiroki Yamamoto on May 1, 2018 and is headquartered in Tokyo, Japan.

Earlyworks Co Ltd - ADR

ELWS is trending due to its low float and recent volatility, with traders actively discussing potential price targets and halt-ups. Community members are also speculating on the impact of blockchain developments and potential partnerships in the Japanese market. Some traders are watching for breakout opportunities and potential short squeezes.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending as investors discuss its potential market reaction to strong earnings, with some anticipating a muted response or a "sell the news" event, while others foresee a delayed pump. Community members are actively debating whether the positive earnings are already priced in and the influence of market makers on the stock's direction. Broader discussions include the impact of AI demand and geopolitical factors on TSM's future performance.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ...

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the European...

NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings

NVDA and PLTR drive AI integration across healthcare, fueling optimism for Omnicell and Tempus AI's Q3 performance.

TEM Expands Partnership With Northwestern Medicine Amid AI Boom

Tempus AI deepens its collaboration with Northwestern Medicine, embedding its AI co-pilot David directly into the health system's EHR to boost clinical efficiency.

Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?

Tempus AI sharpens its edge in precision medicine with key acquisitions, strong R&D launches, and improving financials amid rising competition.

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health...

Short sellers have been increasing their bets against Tempus AI, with short interest hitting a record 25.7% last week, up four percentage points from last week and the highest since the company’s IPO just over a year ago.The rise in bearish positioning comes as volatility in AI-linked stocks intensifies. Tempus AI’s shares, which hit an all-time high on Sept. 22, fell 19% from those levels by Thursday, ending the five-day period down 11%, according to Ortex data compiled by The Fly.&nbsp;The company has been in the spotlight in recent weeks following a string of major announcements. Last month, Tempus AI acquired Paige, a digital pathology firm backed by Memorial Sloan Kettering Cancer Center, for $81.25 million, marking a move CEO Eric Lefkofsky said will accelerate the company’s efforts to build the largest oncology foundation model ever created.&nbsp;Paige’s database of nearly 7 million digitized pathology slides is expected to strengthen Tempus’s AI-driven cancer diagnostics platform.Tempus has also gained recognition from regulatory and government authorities. Earlier this month, it received FDA clearance for its Tempus xR RNA-based diagnostic device and was awarded a $60.57 million contract from the U.S. Department of Health and Human Services to support research initiatives.Meanwhile, Guggenheim recently raised its price target to $95 from $80, maintaining a ‘Buy’ rating after meeting with company executives to discuss its partnership with AstraZeneca and Pathos AI. The firm described Tempus’s oncology foundation model as “highly differentiated.”Meanwhile, Cathie Wood’s Ark Invest has been trimming its position in Tempus, selling shares worth more than $10 million over the past three weeks through the ARK Innovation ETF.On Stocktwits, retail sentiment for Tempus AI was ‘neutral’ amid ‘high’ message volume.One user said the stock appeared to have experienced a failed breakout and faced a strong rejection last week, adding that it now trades “very choppy” and highlighting $90 as a key resistance level.<stembedurl>https://stocktwits.com/trading_momentum_x/message/630288745</stembedurl>Another user dismissed the negative sentiment, suggesting that short sellers were trying to create fear among investors.<stembedurl>https://stocktwits.com/ScreamLikeABaby/message/630273348</stembedurl><a href="https://stocktwits.com/symbol/TEM">Tempus AI’s stock</a> has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration logo of Tempus AI is seen on a smartphone against a screen displaying a trade markets illustration on April 15, 2024 in Krakow, Poland. (Photo by Dominika Zarzycka/NurPhoto via Getty Images)

Tempus AI Stock Sees Heavy Shorting Amid Cathie Wood’s Ark Invest Selloff — Retail Traders Split On Whether Rally Has Peaked

Short interest in Tempus AI climbed to a record 25.7% last week as shares fell 19% from recent highs, even after Guggenheim raised its price target.

Equity

TEM vs. ILMN: Which Precision Oncology Stock Is Worth Buying Now?

As precision oncology advances, Tempus and Illumina lead the way with innovation. Which stock shows stronger growth momentum now?

Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD

TEM secures FDA clearance for its xR IVD device, advancing RNA-based cancer research and precision medicine tools.

Hims & Hers Expands Care Ecosystem via Global and Digital Innovation

HIMS is scaling globally with AI-powered care, new treatments and an $870 million boost to expand its digital ecosystem.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

TEM
Tempus AI Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TEM News

TEMTempus AI Inc